Legislation and Congressional Investigations
We regularly track and advise on virtually every significant pharmaceutical, biotechnology, medical device and healthcare-related legislation considered on Capitol Hill. Our distinct combination of regulatory and public policy experience provides clients with the most effective advocacy in both offensive and defensive legislative matters. We are leaders in helping our clients anticipate and shape new statutory and regulatory challenges, from user fee legislation to drug and device safety-related investigations to changes to government healthcare programs, to the development of new measures to expedite the approval of drugs and devices. We also support clients in efforts to shape state laws such as drug take-back and biologic substitution legislation.